<?xml version="1.0" encoding="UTF-8"?>
<ref id="R33">
 <label>33</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Pu</surname>
    <given-names>D</given-names>
   </name>, 
   <name name-style="western">
    <surname>Yin</surname>
    <given-names>L</given-names>
   </name>, 
   <name name-style="western">
    <surname>Zhou</surname>
    <given-names>Y</given-names>
   </name>, 
   <etal>et al</etal>
  </person-group>
  <article-title>Safety and efficacy of immune checkpoint inhibitors in patients with HBV/HCV infection and advanced-stage cancer: a systematic review</article-title>. 
  <source>Medicine</source>
  <year>2020</year>;
  <volume>99</volume>:
  <elocation-id>e19013</elocation-id>. 
  <pub-id pub-id-type="doi">10.1097/MD.0000000000019013</pub-id>
  <?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/32000444?>
  <pub-id pub-id-type="pmid">32000444</pub-id>
 </mixed-citation>
</ref>
